polski | english | login
Array|Array|Array|Array|Array|Array

DOI: 10.18544/PEDM-20.02.0005
Pediatr Endocrino Diabetes Metab 2014;20,2:69-74

Cardiometabolic risk factors in Turner syndrome

Aneta Gawlik, Joanna Gieburowska, Ewa Małecka-Tendera

keywords: Turner syndrome, metabolic syndrome, cardiometabolic risk factors

Abstract

Congenital cardiovascular structural abnormalities, hypertension, low birth weight, increased prevalence of obesity, frequent glucose intolerance and dyslipidemia are risk factors of premature mortality for cardiovascular events in Turner syndrome (TS). The life expectancy in TS is reduced by at least 10 years and the risk of premature death is increased 3-fold compared to general female population. Hormonal therapy in TS, both estrogens in different algorithms and growth hormone in supraphysiological dose, may additionally modify these factors. In this review we summarize cardiometabolic markers potentially present in girls and women with TS.


Article published in polish language



advanced search »

Article in databases

DOI: 10.18544/PEDM-20.02.0005
PUBMED: view

Similar articles

Growth hormone therapy in a girl with Turner syndrome and diabetes type ...

Risk factors for cardiovascular disease in children with type 1 diabetes ...

Silver-Russell Syndrome – Part I: Clinical Characteristics and Genetic B ...

Pediatric Endocrinology Diabetes and Metabolism

2018; 24, 2: 51-110
2018; 24, 1: 1-50
2017; 23, 4: 169-222
2017; 23, 3: 117-168
2017; 23, 2: 59-116
2017; 23, 1: 1-58
2016; 22, 4: 133-180
2016; 22, 3: 81-132
2016; 22, 2: 43-79
2016; 22, 1: 1-42
2015; 21, 4: 149-191
2015; 21, 3: 97-148
2015; 21, 2: 51-96
2015; 21, 1: 1-50
2014; 20, 4: 131-182
2014; 20, 3: 83-130
2014; 20, 2: 35-82